Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
February 16, 2017 4 mccabe, john j HTML PDF XLS Add to Briefcase
February 14, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS Add to Briefcase
January 12, 2017 CT ORDER confidential treatment order HTML PDF
Add to Briefcase
January 9, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS Add to Briefcase
January 6, 2017 8-K current report HTML PDF XLS Add to Briefcase
December 6, 2016 8-K/A amended current report HTML PDF XLS Add to Briefcase
November 30, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 18, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 14, 2016 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
November 14, 2016 8-K current report HTML PDF XLS Add to Briefcase
1
... NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
1.95
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on February 24, 2017
Delayed at least 20 minutes.